Compare
XPEL, Inc. vs National Presto Industries Inc vs Smith & Wesson Brands, Inc. vs Proto Labs Inc
| Latest fiscal year | XPEL, Inc. XPEL | National Presto Industries Inc NPK | Smith & Wesson Brands, Inc. SWBI | Proto Labs Inc PRLB |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-04-30 | 2025-12-31 |
| Revenue | $476.20M | $503.52M | $523.85M | $533.13M |
| Revenue growth (YoY) | +13.3% | +29.7% | +10.4% | +6.4% |
| Gross margin | 42.2% | 16.0% | 26.9% | 44.5% |
| Operating margin | 13.2% | 8.0% | 5.6% | 4.7% |
| Net margin | 10.8% | 6.6% | 3.5% | 4.0% |
| Net income | $51.23M | $33.08M | $18.48M | $21.24M |
| EPS (Diluted) | $1.85 | n/a | $0.41 | $0.88 |
| Operating cash flow | $66.94M | -$9.14M | $114.19M | $74.50M |
| Free cash flow | $62.93M | -$36.17M | $90.45M | $59.66M |
| Cash & equivalents | $50.86M | $3.25M | $28.19M | $110.83M |
| Total assets | $382.53M | $500.73M | $512.77M | $763.41M |
| Total liabilities | $97.34M | $105.59M | $136.21M | $89.48M |
| Shareholders' equity | $285.19M | $395.13M | $376.56M | $673.93M |
| Return on year-end equity | 18.0% | 8.4% | 4.9% | 3.2% |
| Shares outstanding | 27.60M | 7.12M | 44.61M | 23.63M |
Revenue, most recent five fiscal years
| Fiscal year | XPEL, Inc. | National Presto Industries Inc | Smith & Wesson Brands, Inc. | Proto Labs Inc |
|---|---|---|---|---|
| Latest | $476.20M Ended 2025-12-31 | $503.52M Ended 2025-12-31 | $523.85M Ended 2026-04-30 | $533.13M Ended 2025-12-31 |
| 1 year earlier | $420.40M Ended 2024-12-31 | $388.23M Ended 2024-12-31 | $474.66M Ended 2025-04-30 | $500.89M Ended 2024-12-31 |
| 2 years earlier | $396.29M Ended 2023-12-31 | $340.91M Ended 2023-12-31 | $535.83M Ended 2024-04-30 | $503.88M Ended 2023-12-31 |
| 3 years earlier | $323.99M Ended 2022-12-31 | $321.62M Ended 2022-12-31 | $479.24M Ended 2023-04-30 | $488.40M Ended 2022-12-31 |
| 4 years earlier | $259.26M Ended 2021-12-31 | $355.78M Ended 2021-12-31 | $864.13M Ended 2022-04-30 | $488.10M Ended 2021-12-31 |